执业护士开具丁丙诺啡的处方权：从2000年《药物成瘾治疗法案》到2016年《综合成瘾与康复法案》
Nurse Practitioner Prescriptive Authority for Buprenorphine: From DATA 2000 to CARA 2016.
作者信息
Fornili Katherine S, Fogger Susanne A
机构信息
Katherine S. Fornili, DNP, MPH, RN, CARN, FIAAN, University of Maryland School of Nursing, Baltimore. Susanne A. Fogger, DNP, CRNP, PMHNP-BC, CARN-AP, FAANP, School of Nursing, University of Alabama at Birmingham.
出版信息
J Addict Nurs. 2017 Jan/Mar;28(1):43-48. doi: 10.1097/JAN.0000000000000160.
The aim of this Policy Watch column is to provide an update on a much anticipated legislation, enacted in 2016, which enabled office-based opioid treatment (OBOT) with buprenorphine prescribing for the treatment of opioid addiction by nurse practitioners (as well as physician assistants). First, an overview of the Drug Addiction Treatment Act of 2000, which only permitted OBOT prescribing by physicians, will be described. It will be followed by a summary of the Recovery Enhancement for Addiction Treatment Act of 2015-2016. Finally, a review of the Comprehensive Addiction Recovery Act of 2016 will be provided, which includes information about important changes to OBOT regulations that enable NP prescribing of buprenorphine for the treatment of opioid addiction.
本政策观察专栏的目的是提供关于一项备受期待的立法的最新情况。该立法于2016年颁布，允许执业护士（以及医师助理）在办公室进行阿片类药物治疗（OBOT），开具丁丙诺啡用于治疗阿片类药物成瘾。首先，将介绍2000年的《药物成瘾治疗法》，该法仅允许医生开具OBOT处方。接下来是2015 - 2016年《成瘾治疗康复增强法》的总结。最后，将对2016年的《综合成瘾康复法》进行回顾，其中包括有关OBOT法规重要变化的信息，这些变化使执业护士能够开具丁丙诺啡用于治疗阿片类药物成瘾。
Zotero 插件